Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00381
|
|||||
| Drug Name |
Trimipramine
|
|||||
| Synonyms |
(+)-Trimipramine; (-)-Trimipramine; 1-(3-Dimethylamino-2-methylpropyl)-4,5-dihydro-2,3:6,7-dibenzazepine; 10,11 Dihydro-N,N,beta-trimethyl-5H-dibenz(b,f)azepine-5-propanamine; 10,11-Dihydro-5-(3-dimethylamino-2-methylpropyl)-5H-dibenz(b,f)azepine; 10,11-dihydro-N,N,beta-trimethyl-5H-dibenz[b,f]azepine-5-propanamine; 2'-Metil-3'-dimetilamino-propil-5-iminodibenzile; 2'-Metil-3'-dimetilamino-propil-5-iminodibenzile [Italian]; 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine; 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethylpropan-1-amine; 5-(3-(Dimethylamino)-2-methylpropyl)-10,11-dihydro-5H-dibenz(b,f)azepine; 5-(gamma-Dimethylamino-beta-methylpropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine; 5-(gamma-dimethylamino-beta-methylpropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine; 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-5H-dibenz[b,f]azepine; 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-, (+)-(9CI); 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-, (-)-(9CI); 7162 RP; Beta-Methylimipramine; FI 6120; IL 6001; IL-6001; RP-7162; Rhotrimine (TN); Sapilent; Stangyl; Stangyl (TN); Surmontil; Surmontil (TN); Surmontyl; Trimeprimina; Trimeprimina [Italian]; Trimeprimine; Trimeproprimin; Trimeproprimine; Trimipramina; Trimipramina [INN-Spanish]; Trimipramine (USAN/INN); Trimipramine [USAN:INN:BAN]; Trimipramine, (-)-Isomer; Trimipraminum; Trimipraminum [INN-Latin]
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antidepressants
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C20H26N2
|
|||||
| Canonical SMILES |
CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
|
|||||
| InChI |
InChI=1S/C20H26N2/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22/h4-11,16H,12-15H2,1-3H3
|
|||||
| InChIKey |
ZSCDBOWYZJWBIY-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 739-71-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 294.4 | Topological Polar Surface Area | 6.5 | ||
| Heavy Atom Count | 22 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
5.8
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103189045
, 10534352
, 11335268
, 11360507
, 11364316
, 11366878
, 11369440
, 11372300
, 11374257
, 11377602
, 11461479
, 11466834
, 11467954
, 11485056
, 11486328
, 11489346
, 11490966
, 11492574
, 11495236
, 14751475
, 29214834
, 29224622
, 46507121
, 47216629
, 47365025
, 47515163
, 4752050
, 47588839
, 47810599
, 47959573
, 48034950
, 48259062
, 48334324
, 48416674
, 49698932
, 49761600
, 49961515
, 49961516
, 49961517
, 50111256
, 57322857
, 7847460
, 78776395
, 7980837
, 8153438
, 85209670
, 85789363
, 90341093
, 92714629
, 92729770
|
|||||
| ChEBI ID |
ChEBI:9738
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.